Duster Inhalation Prevention Act
- Sponsor
- Sen. Wyden, Ron [D-OR]
- Committees
- Commerce, Science, and Transportation Committee (primary)
- Last action
- Jul 15, 2026
Bottom line
This bill aims to prevent inhalant abuse by classifying certain chemicals in compressed air dusters as hazardous and banning products exceeding a specified threshold, while giving the CPSC ongoing regulatory authority.
What it actually does
This bill mandates the Consumer Product Safety Commission (CPSC) to classify specific hydrofluorocarbons (HFC-152a, HFC-134a, and derivatives) found in aerosol duster products as hazardous substances. It then bans aerosol duster products containing more than 18 mg of these substances and prohibits manufacturers from stockpiling such products before the ban takes effect. The bill also grants the CPSC authority to add other harmful propellants to the hazardous substances list through regulation.
Proponents argue
Supporters argue that this legislation is a critical measure to protect public health and safety, particularly among youth, by directly addressing the dangers of recreational inhalant abuse. They contend that classifying these chemicals as hazardous and banning products containing them will significantly reduce access to substances known to cause serious health issues, injury, or death.
Opponents contend
Opponents might argue that the bill could impose undue burdens on manufacturers, potentially leading to increased costs for product reformulation or reduced availability of legitimate cleaning tools for consumers. They may also contend that a blanket ban, rather than targeted education or age restrictions, is an overreach that could disrupt markets unnecessarily.
The bill is very concise and clearly written, making it accessible for a quick and thorough understanding of its provisions.
Section 3(a)
Designating Specific HFCs as Hazardous Substances
This section mandates the Consumer Product Safety Commission (CPSC) to declare 1,1-difluoroethane (HFC-152a), 1,1,1,2-tetrafluoroethane (HFC-134a), and any derivative products of these chemicals as hazardous substances under the Federal Hazardous Substances Act. This classification provides the legal foundation for subsequent regulatory actions against products containing these chemicals.
Supporters argue
Supporters argue that classifying these specific HFCs as hazardous is a necessary and appropriate step given their known dangers when intentionally inhaled, providing the essential legal basis for protective public health measures.
Critics contend
Some manufacturers might argue that these chemicals are safe when used as intended for cleaning and that this classification is an overreaction that could unfairly stigmatize legitimate products.
Tradeoffs
This provision balances the imperative of public safety, particularly concerning inhalant abuse, against potential regulatory burdens on the industry and potential impacts on consumer access to existing products.
Section 3(b)
Banning Duster Products Exceeding HFC Threshold
This provision declares that any aerosol duster product, or other aerosol product, containing more than 18 mg of the newly classified hazardous HFCs (HFC-152a, HFC-134a, or their derivatives) shall be considered a banned hazardous substance under the Federal Hazardous Substances Act. This effectively prohibits the manufacture, sale, and distribution of such products.
Section 3(d)
CPSC Authority to Add Additional Harmful Propellants
This provision grants the Consumer Product Safety Commission (CPSC) the authority to add other harmful propellants, beyond those initially specified, to the list of hazardous substances. This can be done through a regulatory process (in accordance with section 553 of title 5, United States Code), allowing the CPSC to adapt to new chemicals or emerging trends in recreational inhalant abuse.
Defines "stockpile" as the manufacturing or importing of aerosol duster products at a rate greater than 105 percent of the average monthly volume during the 13-month period immediately preceding the date of enactment of this Act.
Section 2(5)
Why it matters:This is standard legislative practice to define terms upfront, but the specific numerical threshold (105%) is a key operational detail for industry compliance and enforcement, making it consequential despite its placement.
Case for: This definition is crucial for preventing manufacturers from circumventing the intent of the ban by producing a large inventory of soon-to-be-banned products before the effective date, thereby ensuring the policy's immediate and full impact on the market.
Case against: Manufacturers might argue that such a specific and potentially restrictive definition could interfere with normal business operations, supply chain management, or their ability to meet legitimate consumer demand during a transition period, even without an intent to circumvent the ban.
Estimated impact: Prevents a surge in the supply of banned products, ensuring that the market clears more quickly and the public health benefits of the ban are realized sooner.
States that nothing in this Act shall apply to drugs regulated by the Food and Drug Administration (FDA).
Section 3(e)
Why it matters:This is a common legislative practice to clarify jurisdictional boundaries and prevent unintended overlap or conflict with existing regulatory frameworks, particularly for highly regulated sectors like pharmaceuticals.
Case for: This provision ensures that essential medical products, which might contain similar propellants but are rigorously regulated for safety and efficacy by the FDA, are not inadvertently banned. This prevents disruption to healthcare and ensures continued patient access to necessary medications.
Case against: No significant case against this provision, as it serves to prevent unintended negative consequences and jurisdictional conflicts, which are generally undesirable in legislation.
Estimated impact: Preserves the availability of FDA-approved drugs that may utilize aerosol propellants, ensuring that medical treatments are not disrupted by the new regulations.